![]() ![]() Before and after 16 weeks of treatment, all subjects received a 75-g oral glucose tolerance test (OGTT) and hepatic and peripheral insulin sensitivity was measured with a two-step euglycemic insulin (40 and 160 mU RESEARCH DESIGN AND METHODS-A total of 23 diabetic patients (age 30–70 years, BMI < 36 kg/m 2) who were being treated with a stable dose of sulfonylurea were randomly assigned to receive either placebo ( n = 11) or pioglitazone (45 mg/day) ( n = 12) for 16 weeks. ![]() OBJECTIVE-To elucidate the effects of pioglitazone treatment on glucose and lipid metabolism in patients with type 2 diabetes.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |